Maruko, Ichiro http://orcid.org/0000-0001-5647-6372
Okada, Annabelle A.
Iida, Tomohiro
Hasegawa, Taiji
Izumi, Takahiko
Kawai, Moeko
Maruko, Ruka
Nakayama, Makiko
Yamamoto, Akiko
Koizumi, Hideki
Tamashiro, Tamaki
Terao, Nobuhiro
Wakugawa, Sorako
Mori, Ryusaburo
Onoe, Hajime
Tanaka, Koji
Wakatsuki, Yu
Itagaki, Kanako
Kasai, Akihito
Ogasawara, Masashi
Sekiryu, Tetsuju
Shintake, Hiroaki
Sugano, Yukinori
,
Funding for this research was provided by:
JSPS KAKENHI (Grant Number JP20K09781)
Article History
Received: 13 January 2021
Revised: 20 February 2021
Accepted: 26 February 2021
First Online: 15 March 2021
Declarations
:
: This was a retrospective study, and the procedures used conformed to the tenets of the Declaration of Helsinki. The Institutional Review Boards of Kyorin University, Fukushima Medical University, Nihon University, Tokyo Women’s Medical University, and University of the Ryukyus approved the procedures used. Informed consent was obtained from all individual participants included in the study.
: Dr Maruko reported grants from JSPS KAKENHI (Grant Number JP20K09781); personal fees from Alcon, Bayer, Canon, Nidek, Novartis, Santen, Senju, and Topcon outside the submitted work.Dr Okada reported consulting fees from Astellas, Bayer, Biocon Biologics, Daiichi Sankyo, HOYA, Kowa, and Novartis; personal support from Abbvie, Alcon, Bayer, Mitsubishi Tanabe, Novartis, Pfizer, Santen, and Senju outside the submitted work.Dr Iida reported consulting fees from Bayer and Chugai; personal fees from AMO, Alcon, Bayer, Canon, HOYA, JFC, Kowa, Nikon, Nidek, Novartis, Otsuka, Pfizer, Santen, Senju, and Topcon outside the submitted work.